肝动脉化学治疗栓塞术治疗38例中晚期原发性肝癌危险因素分析  

Analysis of risk factors of transcatheter arterial chemoembolization on 38 cases of intermediate and late primary hepatocarcinoma

作　　者：朴正日[1] 金花[1] 李兰[1] 黄京华[1] 

机构地区：[1]延边大学附属医院肿瘤科,吉林延吉133000

出　　处：《延边大学医学学报》2017年第1期59-61,共3页Journal of Medical Science Yanbian University

摘　　要：[背景]观察肝动脉化学治疗栓塞术(TACE)的危险因素.[病例报告]选择接受TACE治疗的38例中晚期原发性肝癌患者的临床资料,分为TACE治疗后1个月内因肝功能衰竭死亡组(7例)及接受TACE治疗后生存时间超过6个月以上组(31例).比较两组血常规4项及肝功能检查11项指标水平.结果见,两组血常规4项指标值间差异均无统计学意义(P>0.05),而肝功能检查11项指标中胆红素、吲哚菁绿、白蛋白、口服葡萄糖耐量试验4个项目水平间差异均具有统计学意义(P<0.01,P<0.005).[讨论]给予TACE治疗时应注意保护肝功能.BACKGROUND To investigate the risk factors of transcatheter arterial chemoembolization（TACE）.CASE REPORTS The clinical data of 38 cases of intermediate and late primary hepatocarcinoma who accepted the treatment of TACE were selected.They were divided into two groups,one group had7 patients who died of hepatic failure within 1month after TACE,another group contained 31 patients who survived for more than half a year after TACE.The results of blood routine examination and liver function test were compared between the two groups.No significant differences were observed in blood routine examination between the two groups（P〉0.05）.However the values of bilirubin,indocyanine green and albumin and oral glucose tolerance test showed significant difference（P〈0.01,P〈0.005）.DISCUSSION We should pay attention to protect the hepatic function when giving the treatment of TACE.

关 键 词：肝癌 栓塞化学治疗 肝功能 危险因素 

分 类 号：R735.7[医药卫生—肿瘤]